Philips Wins Dutch Court Battle With Shareholders Over Sleep Apnea Recall

What happened

The Enterprise Chamber of the Amsterdam Court of Appeal on Saturday, October 11, 2026 dismissed a shareholder demand for an independent, in-depth investigation into Philips over allegations of misleading disclosures and management failures tied to the company's sleep apnea device recall, according to NL Times, which reported the ruling at 09:45 that morning. The demand had been brought by the Dutch Investors' Association, known as the VEB, together with a large group of shareholders, who argued that Philips executives "responded too late" to the problems that led to the recall and "failed to adequately inform investors," as reported by The Express Tribune. The court found "no indication that Philips had known about the problems long before it issued any warning" and "no reason to assume executives should have intervened earlier at the Respironics subsidiary that made the devices," the Express Tribune reported, quoting the ruling. Philips denied the shareholders' accusations and said it "welcomed the court's decision." The recall itself dates to 2021, when Philips pulled roughly 15 million sleep apnea devices from the market, a figure cited by Ground News and the Express Tribune, after discovering that sound-dampening foam inside the machines could crumble and release possibly harmful chemicals. NL Times puts the figure somewhat differently, citing more than 3 million DreamStation respiratory machines, mostly sold in the United States. Patients had reported headaches, vomiting and other symptoms, and Philips shares lost about two-thirds of their value when the recall became public.

Why it matters

The ruling closes one of the most consequential chapters of a scandal that has shadowed Philips for five years and wiped out roughly two-thirds of the company's market value. The financial trail is substantial: Philips first set aside €250 million for expected recall costs, then raised that provision in four steps to €970 million. In 2023 the company agreed to pay €448 million to tens of thousands of American DreamStation users without admitting the devices caused health issues, and a larger €1.1 billion settlement followed in 2024, according to NL Times. A court finding that executives neither knew of the foam problem early nor should have intervened sooner at Respironics removes a legal avenue through which shareholders could have sought accountability for the collapse in the share price and the mounting settlement costs. For the VEB, which has pursued the case on behalf of a large group of investors, the dismissal means the alleged disclosure failures will not be examined by an independent investigator with powers to compel documents and testimony. The ruling also matters beyond the Netherlands: it is the kind of judicial finding that other courts, regulators and plaintiffs' lawyers weighing similar claims over the recall are likely to weigh. At the same time, the decision does not end Philips' exposure. The company still faces ongoing international probes related to the recall, per the Ground News summary of the story, so the legal and financial tail of the 2021 recall continues even after this defeat for shareholders in Amsterdam.

How it is being covered

Ground News counts 29 sources carrying the story, of which 17 are rated, with 11 rated high factuality and 3 very high. The political split is 6 percent left, 47 percent center and 47 percent right, which makes the story a blindspot on the left: only 1 of the 17 rated sources is left-leaning, per Ground News. Coverage in the available reporting is factual and ruling-centred, with both NL Times and the Express Tribune leading on the court's rejection of the investigation rather than on the underlying health claims.

What to watch

Three threads remain open. First, the ongoing international probes into the recall, which the Ground News summary flags as still running; any findings or charges from those investigations would land on top of the €1.1 billion already committed in settlements. Second, whether the VEB or other shareholder groups pursue alternative legal routes after the Enterprise Chamber's dismissal, since the court rejected an investigation but the underlying disputes over disclosure and timing could resurface in other forums. Third, the gap between the two recall figures in circulation, roughly 15 million devices on the Ground News and Express Tribune count versus more than 3 million DreamStation machines per NL Times, which reflects differing scopes of what is being counted and is worth tracking as coverage develops. Any further provision changes, new settlement announcements or regulatory action would extend a cost line that has already moved from €250 million to €970 million in provisions plus €448 million and €1.1 billion in settlements.

By the numbers

Source snapshot